메뉴 건너뛰기




Volumn 9, Issue 11, 2011, Pages 2235-2242

Functional factor VIII made with von Willebrand factor at high levels in transgenic milk

Author keywords

Factor VIII; Hemophilia; Mammary gland; Modified B domain; Recombinant protein; Transgenic animal; Von Willebrand factor

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 8; THROMBOPLASTIN; VON WILLEBRAND FACTOR; BLOOD CLOTTING FACTOR 8;

EID: 80055102461     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04505.x     Document Type: Article
Times cited : (10)

References (40)
  • 2
    • 0025017341 scopus 로고
    • The increasing prevalence of haemophilia
    • Rosendaal FR, Briet E. The increasing prevalence of haemophilia. Thromb Haemost 1990; 63: 145.
    • (1990) Thromb Haemost , vol.63 , pp. 145
    • Rosendaal, F.R.1    Briet, E.2
  • 3
    • 0028078717 scopus 로고
    • Hemophilia A
    • Hoyer LW. Hemophilia A. N Engl J Med 1994; 330: 38-47.
    • (1994) N Engl J Med , vol.330 , pp. 38-47
    • Hoyer, L.W.1
  • 8
    • 44349150005 scopus 로고    scopus 로고
    • Progress in the molecular biology of inherited bleeding disorders
    • Pipe SW, High KA, Ohashi K, Ural AU, Lillicrap D. Progress in the molecular biology of inherited bleeding disorders. Haemophilia 2008; 14(Suppl. 3): 130-7.
    • (2008) Haemophilia , vol.14 , Issue.SUPPL.. 3 , pp. 130-137
    • Pipe, S.W.1    High, K.A.2    Ohashi, K.3    Ural, A.U.4    Lillicrap, D.5
  • 9
    • 11044224626 scopus 로고    scopus 로고
    • New high-technology products for the treatment of haemophilia
    • Pipe SW, Saint-Remy J-M, Walsh CE. New high-technology products for the treatment of haemophilia. Haemophilia 2004; 10: 55-63.
    • (2004) Haemophilia , vol.10 , pp. 55-63
    • Pipe, S.W.1    Saint-Remy, J.-M.2    Walsh, C.E.3
  • 10
    • 0027237331 scopus 로고
    • Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production
    • Lynch CM, Israel DI, Kaufman RJ, Miller AD. Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production. Hum Gene Ther 1993; 4: 259-72.
    • (1993) Hum Gene Ther , vol.4 , pp. 259-272
    • Lynch, C.M.1    Israel, D.I.2    Kaufman, R.J.3    Miller, A.D.4
  • 11
    • 0029098922 scopus 로고
    • Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation
    • Koeberl DD, Halbert CL, Krumm A, Miller AD. Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation. Hum Gene Ther 1995; 6: 469-79.
    • (1995) Hum Gene Ther , vol.6 , pp. 469-479
    • Koeberl, D.D.1    Halbert, C.L.2    Krumm, A.3    Miller, A.D.4
  • 13
    • 0023918719 scopus 로고
    • Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells
    • Kaufman RJ, Wasley LC, Dorner AJ. Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem 1988; 263: 6352-62.
    • (1988) J Biol Chem , vol.263 , pp. 6352-6362
    • Kaufman, R.J.1    Wasley, L.C.2    Dorner, A.J.3
  • 15
    • 0026565453 scopus 로고
    • A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage
    • Pittman DD, Millenson M, Marquette K, Bauer K, Kaufman RJ. A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage. Blood 1992; 79: 389-97.
    • (1992) Blood , vol.79 , pp. 389-397
    • Pittman, D.D.1    Millenson, M.2    Marquette, K.3    Bauer, K.4    Kaufman, R.J.5
  • 16
    • 0024597022 scopus 로고
    • Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells
    • Kaufman RJ, Wasley LC, Davies MV, Wise RJ, Israel DI, Dorner AJ. Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Mol Cell Biol 1989; 9: 1233-42.
    • (1989) Mol Cell Biol , vol.9 , pp. 1233-1242
    • Kaufman, R.J.1    Wasley, L.C.2    Davies, M.V.3    Wise, R.J.4    Israel, D.I.5    Dorner, A.J.6
  • 17
    • 0035988814 scopus 로고    scopus 로고
    • Temporal and spatial expression of biologically active human factor VIII in the milk of transgenic mice driven by mammary-specific bovine lactalbumin regulation sequences
    • Chen C-M, Wang C-H, Wu S-C, Lin C-C, Lin S-H, Cheng WTK. Temporal and spatial expression of biologically active human factor VIII in the milk of transgenic mice driven by mammary-specific bovine lactalbumin regulation sequences. Transgenic Res 2002; 11: 257-68.
    • (2002) Transgenic Res , vol.11 , pp. 257-268
    • Chen, C.-M.1    Wang, C.-H.2    Wu, S.-C.3    Lin, C.-C.4    Lin, S.-H.5    Cheng, W.T.K.6
  • 20
    • 0033150573 scopus 로고    scopus 로고
    • Expression of human blood clotting factor VIII in the mammary gland of transgenic sheep
    • Niemann H, Halter R, Carnwath JW, Hermann D, Lemme E, Paul D. Expression of human blood clotting factor VIII in the mammary gland of transgenic sheep. Transgenic Res 1999; 8: 237-47.
    • (1999) Transgenic Res , vol.8 , pp. 237-247
    • Niemann, H.1    Halter, R.2    Carnwath, J.W.3    Hermann, D.4    Lemme, E.5    Paul, D.6
  • 23
    • 0025285392 scopus 로고
    • High-level expression of biologically active human alpha 1-antitrypsin in the milk of transgenic mice
    • Archibald AL, McClenaghan M, Hornsey V, Simons JP, Clark AJ. High-level expression of biologically active human alpha 1-antitrypsin in the milk of transgenic mice. Proc Natl Acad Sci USA 1990; 87: 5178-82.
    • (1990) Proc Natl Acad Sci USA , vol.87 , pp. 5178-5182
    • Archibald, A.L.1    McClenaghan, M.2    Hornsey, V.3    Simons, J.P.4    Clark, A.J.5
  • 25
    • 0028058606 scopus 로고
    • Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage
    • Michnick DA, Pittman DD, Wise RJ, Kaufman RJ. Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage. J Biol Chem 1994; 269: 20095-102.
    • (1994) J Biol Chem , vol.269 , pp. 20095-20102
    • Michnick, D.A.1    Pittman, D.D.2    Wise, R.J.3    Kaufman, R.J.4
  • 28
    • 0029957538 scopus 로고    scopus 로고
    • Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies
    • Bi L, Sarkar R, Naas T, Lawler AM, Pain J, Shumaker SL, Bedian V, Kazazian HH Jr. Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies. Blood 1996; 88: 3446-50.
    • (1996) Blood , vol.88 , pp. 3446-3450
    • Bi, L.1    Sarkar, R.2    Naas, T.3    Lawler, A.M.4    Pain, J.5    Shumaker, S.L.6    Bedian, V.7    Kazazian Jr, H.H.8
  • 30
    • 0030999953 scopus 로고    scopus 로고
    • Transgene rescue in the mammary gland is associated with transcription but does not require translation of BLG transgenes
    • Yull F, Binas B, Harold G, Wallace R, Clark AJ. Transgene rescue in the mammary gland is associated with transcription but does not require translation of BLG transgenes. Transgenic Res 1997; 6: 11-17.
    • (1997) Transgenic Res , vol.6 , pp. 11-17
    • Yull, F.1    Binas, B.2    Harold, G.3    Wallace, R.4    Clark, A.J.5
  • 31
    • 3242781567 scopus 로고    scopus 로고
    • Overcoming the immunological barriers to curing haemophilia
    • In: Studies TSIfB, ed. La Jolla, CA: The Salk Institute for Biological Studies
    • Alpan O, Velander WH, van Cott KE, Butler SP, High KA, Sabatino D. Overcoming the immunological barriers to curing haemophilia. In: Studies TSIfB, ed. 6th Gene Therapy Workshop. La Jolla, CA: The Salk Institute for Biological Studies, 2002: 3885-91.
    • (2002) 6th Gene Therapy Workshop , pp. 3885-3891
    • Alpan, O.1    Velander, W.H.2    van Cott, K.E.3    Butler, S.P.4    High, K.A.5    Sabatino, D.6
  • 35
    • 0017754787 scopus 로고
    • Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease
    • Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 1977; 60: 390-404.
    • (1977) J Clin Invest , vol.60 , pp. 390-404
    • Weiss, H.J.1    Sussman, I.I.2    Hoyer, L.W.3
  • 36
    • 0025924755 scopus 로고
    • Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor
    • Leyte A, van Schijndel HB, Niehrs C, Huttner WB, Verbeet MP, Mertens K, van Mourik JA. Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J Biol Chem 1991; 266: 740-6.
    • (1991) J Biol Chem , vol.266 , pp. 740-746
    • Leyte, A.1    van Schijndel, H.B.2    Niehrs, C.3    Huttner, W.B.4    Verbeet, M.P.5    Mertens, K.6    van Mourik, J.A.7
  • 37
    • 80055106618 scopus 로고    scopus 로고
    • First attempt at immune tolerance induction with factor VIII/von Willebrand factor concentrates in hemophilia A children with high-titer inhibitors
    • Platokouki H, Pergantou H, Komitopoulou A, Xafaki P. First attempt at immune tolerance induction with factor VIII/von Willebrand factor concentrates in hemophilia A children with high-titer inhibitors. J Coagulation Disord 2010; 2: 35-40.
    • (2010) J Coagulation Disord , vol.2 , pp. 35-40
    • Platokouki, H.1    Pergantou, H.2    Komitopoulou, A.3    Xafaki, P.4
  • 38
    • 33747171681 scopus 로고    scopus 로고
    • Production of recombinant therapeutic proteins in the milk of transgenic animals
    • 2, 4, 6.
    • Echelard Y, Ziomek CA, Meade HM. Production of recombinant therapeutic proteins in the milk of transgenic animals. BioPharm Int. 2006; 19: 36-40, 2, 4, 6.
    • (2006) BioPharm Int , vol.19 , pp. 36-40
    • Echelard, Y.1    Ziomek, C.A.2    Meade, H.M.3
  • 39
    • 45749147034 scopus 로고    scopus 로고
    • Analysis of the N-glycans of recombinant human factor IX purified from transgenic pig milk
    • Gil GC, Velander WH, van Cott KE. Analysis of the N-glycans of recombinant human factor IX purified from transgenic pig milk. Glycobiology 2008; 18: 526-39.
    • (2008) Glycobiology , vol.18 , pp. 526-539
    • Gil, G.C.1    Velander, W.H.2    van Cott, K.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.